Amgen Inc.
AMGN
$307.31
$7.012.33%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 7.12B | 7.83B | 6.55B | 6.68B | 5.85B |
| Total Other Revenue | 329.00M | 363.00M | 355.00M | 303.00M | 259.00M |
| Total Revenue | 7.45B | 8.20B | 6.90B | 6.99B | 6.11B |
| Cost of Revenue | 3.20B | 3.11B | 1.81B | 1.81B | 1.72B |
| Gross Profit | 4.25B | 5.08B | 5.10B | 5.17B | 4.39B |
| SG&A Expenses | 1.81B | 2.27B | 1.34B | 1.29B | 1.26B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 103.00M | 620.00M | -9.00M | 57.00M | 143.00M |
| Total Operating Expenses | 6.45B | 7.53B | 4.22B | 4.26B | 4.18B |
| Operating Income | 993.00M | 668.00M | 2.69B | 2.73B | 1.93B |
| Income Before Tax | -68.00M | 852.00M | 1.95B | 1.61B | 3.44B |
| Income Tax Expenses | 45.00M | 85.00M | 217.00M | 235.00M | 601.00M |
| Earnings from Continuing Operations | -113.00M | 767.00M | 1.73B | 1.38B | 2.84B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -113.00M | 767.00M | 1.73B | 1.38B | 2.84B |
| EBIT | 993.00M | 668.00M | 2.69B | 2.73B | 1.93B |
| EBITDA | 2.39B | 2.05B | 3.58B | 3.62B | 2.83B |
| EPS Basic | -0.21 | 1.43 | 3.23 | 2.58 | 5.32 |
| Normalized Basic EPS | 0.43 | 0.12 | 2.84 | 1.11 | 1.87 |
| EPS Diluted | -0.21 | 1.42 | 3.22 | 2.57 | 5.28 |
| Normalized Diluted EPS | 0.43 | 0.12 | 2.82 | 1.11 | 1.85 |
| Average Basic Shares Outstanding | 536.00M | 535.00M | 535.00M | 535.00M | 534.00M |
| Average Diluted Shares Outstanding | 536.00M | 540.00M | 538.00M | 537.00M | 538.00M |
| Dividend Per Share | 2.25 | 2.13 | 2.13 | 2.13 | 2.13 |
| Payout Ratio | -1,069.03% | 148.63% | 65.90% | 82.60% | 40.02% |
